|
|
|
Press Releases
MILESTONE SCIENTIFIC RECEIVES NOTICE OF ALLOWANCE FROM U.S.
PATENT AND TRADEMARK OFFICE
Protects Core Intellectual Property Underlying
Award-Winning
STA Single Tooth Anesthesia System™Through December 2026
PISCATAWAY, N.J. – (PR NEWSWIRE) – September
16, 2009 – Milestone Scientific Inc. (OTCBB:MLSS),
the recognized leader in advanced injection technologies, today announced
that the United States Patent and Trademark Office has issued a Notice
of Allowance for Milestone’s U.S. patent application, titled “Computer
Controlled Drug Delivery System with Dynamic Pressure Sensing.”
Dynamic Pressure Sensing provides visual and audible in-tissue pressure
feedback, identifying tissue types to the healthcare provider. This
feedback allows a healthcare provider to know when certain types of tissue
have been penetrated, allowing for the injection of medicaments at a
precise location. This is particularly beneficial when making subcutaneous
and intramuscular injections.
Dr. Mark Hochman, Director of Clinical Affairs at Milestone Scientific,
stated, “This Notice of Allowance is of profound significance to
our Company, in that the noted intellectual property represents one of
the key technological components that will afford Milestone Scientific
the opportunity to enter the medical drug delivery market. Intra-articular,
epidurals, along with numerous other injections should undergo a revolutionary
change in the areas of efficacy, safety, and cost benefits.”
A Notice of Allowance generally completes the substantive examination
of a patent application. The normal process, which results in a
final issuance of a U.S. patent, involves several administrative steps
that are typically completed in due course following the issuance of
such a Notice.
The new patent will provide protection for a key element of Milestone’s
technology until December 21, 2026 and thus will extend and strengthen
Milestone’s leadership position in the growing field of advanced
injection and drug delivery systems. To date, Milestone has been
awarded a total of 22 U.S. utility and design patents relating to its
C-CLAD technologies. In August of this year, the Company received
a Notice of Allowance for the bonded disposable hand piece for fluid
administration used by the Company’s commercially available C-CLAD
systems, including the STA Single Tooth Anesthesia System™,
CompuDent® and CompuMed®.
“We are very proud of our Company’s technological achievements
and expect that the protection afforded by these patents will give Milestone
a key competitive advantage in the drug delivery market,” added Leonard
Osser, Milestone’s CEO. In June 2008, Business Insights reported
that over the last decade, the drug delivery industry has evolved to become
a key area in the development of value-added pharmaceutical products. The
global market grew from $15 billion to $40 billion during 2000-2006 as
companies increasingly turned to innovative new drug delivery technologies
as a means of expanding product lifecycles, enhancing drug efficacy and
maximizing revenues.
About Milestone Scientific Inc.
Headquartered in Piscataway, New Jersey, Milestone Scientific is engaged
in pioneering proprietary, highly innovative technological solutions
for the medical and dental markets. Central to the Company’s
IP platform and product development strategy is its patented CompuFlo® technology
for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is
a computer-controlled, pressure sensitive infusion, perfusion, suffusion
and aspiration technology, which provides real-time readouts of pressures,
fluid densities and flow rates, enabling the advanced delivery and
removal of a wide array of fluids. The STA Single
Tooth Anesthesia System™, a computer-controlled local anesthesia
delivery system, uses this technology to provide dentists with audible
and visual signals as to in-tissue pressure. Milestone’s
existing painless injection systems are currently sold in 25 countries. For
more information on these and other innovative Milestone products,
please visit the Company’s web site found at www.milestonescientific.com and www.STAis4U.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group
Dodi Handy, President and CEO
For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite
Media Group
407-585-1080 or via email at mlss@efcg.net
|
